The 22nd International AIDS Conference (AIDS 2018) took place in Amsterdam, the Netherlands, from 23 to 27 July 2018.

Conference highlights

PARTNER 2 study

Zero transmissions mean zero risk – PARTNER 2 study results announced.

Conference bulletins

Read our AIDS 2018 conference bulletins in English, French, Spanish, Portuguese and Russian.

U=U campaign

The “Undetectable = Untransmittable” message goes global: I=I, N=N and B=B.


Young people

Progress against HIV in young people lags behind as Africa's youth population grows.

aidsmapLIVE

Watch our AIDS 2018 aidsmapLIVE panel discussion on Facebook.

PrEP in the US

PrEP use linked to fewer new HIV infections in US states.


Treatment guidelines

Dolutegravir-based ART recommended for all – if reliable contraception is available.

The search for a cure

The kick that didn’t kill: first-ever randomised HIV cure study fails to eliminate infected cells.

HIV and the criminal law

World experts publish consensus statement on the science of HIV in the context of criminal law.


aidsmap news from AIDS 2018

← First123Next →

Editors' picks from other sources

Subscribe now

Sign up for our email bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more on the official conference website.

Visit the AIDS 2018 website >

Amsterdam 2018: the Undetectable conference

NAM aidsmap Editor Gus Cairns has written a piece for NAM news and opinions on why he thinks AIDS 2018 will be remembered as the U=U and PrEP conference.

Read Gus's post >

Scientific analysis from Clinical Care Options

Engage in the scientific analysis of AIDS 2018, with downloadable slides and expert faculty commentary on key HIV prevention and treatment studies from Clinical Care Options.

Visit the CCO website >

NAM's news coverage of the 22nd International AIDS Conference has been supported by Gilead Sciences Europe Ltd. and ViiV Healthcare.



Official conference partners

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.